£2.77m
+44%vs Jun 2024Active10228159Private limited companyNottingham
EXCELLERATE BIOSCIENCE LIMITED
Significant control: Excellerate Bioscience Holdings Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Excellerate Bioscience Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
EXCELLERATE BIOSCIENCE LIMITED is an active private limited company (company number 10228159) incorporated on 13 June 2016, registered in Nottingham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £2.77m and cash of £1.65m, with 31 employees on average. Net assets rose 44% on the prior period (£1.93m).
Peer position · net assets
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Excellerate Bioscience Holdings Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Viral Patel
- owns 25–50% of shares
- Mr Steven John Charlton
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Sukhjinder Singh Chahal
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Viral Laxmiprasad Patel
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 13 June 201610 yrs ago
- Next accounts due
- 30 March 2027in 158 days
- Confirmation statement due
- 27 June 2027in 247 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£1.65m
+1%vs Jun 2024Not reported
31
+29%vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £2.77m | £1.65m | £848k | £522k | — | — | 31 |
| 30 June 2024 | £1.93m | £1.63m | £254k | £647k | — | — | 24 |
Current ratio4.79Current assets ÷ creditors within one year
Cash per employee£53kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,773,629 at 30 June 2025
- Net assets up 10% or more on the prior period+43.9% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.79
- Cash at bank of £50,000 or moreCash £1,651,692
- Incorporated five or more years agoIncorporated 13 June 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 247 days
- Next accounts duein 158 days
- Accounts period endNet assets £2.77m · small accounts
- Accounts period endNet assets £1.93m · small accounts
- Incorporated
08
Similar companies in Nottingham
- NESTTECK LTDMansfield · inc. Apr 2016
- SELENTUS SCIENCE LIMITEDGrantham · inc. Apr 2016
- BIOSCIENCES BIOSCI LIMITEDNewark · inc. Aug 2016
- WATCH BIDCO LIMITEDNottingham · inc. Nov 2015
- CELLOMATICS BIOSCIENCES LIMITEDColwick · inc. Sept 2015
- QUOTIENT SCIENCES (ALNWICK) LIMITEDNottingham · inc. Sept 2015
All companies incorporated on 13 June 2016 · in Jun 2016.
09
Reminders for EXCELLERATE BIOSCIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.